FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225699651> ?p ?o ?g. }

• W4225699651 endingPage "513" @default.
• W4225699651 startingPage "503" @default.
• W4225699651 abstract "The Academic Research Consortium - High Bleeding Risk (ARC-HBR) initiative defined conditions associated with percutaneous coronary intervention (PCI)-related bleeding.We sought to further explore these HBR conditions in the setting of transcatheter aortic valve replacement (TAVR).Patients from the SCOPE 2 trial were stratified by their bleeding risk status based on the ARC-HBR definitions. Baseline and procedural characteristics, as well as key clinical outcomes including Bleeding Academic Research Consortium (BARC) 3-5 bleeding, were compared in ARC-HBR positive (HBR+) and ARC-HBR negative (HBR-) patients.Of 787 patients randomised in SCOPE 2 and included in this study, 633 were HBR+ (80.4%). Compared with HBR- patients, those HBR+ were older and more frequently presented with diabetes, a history of coronary artery disease, atrial fibrillation, prior cerebrovascular accident, and a Society of Thoracic Surgeons predicted risk of 30-day mortality (STS-PROM) (4.9±2.9% vs 3.3%±2.1%; p<0.0001). In addition, HBR+ patients were more frequently on oral anticoagulation therapy. At 1 year, HBR+ patients had higher rates of all-cause death (12.4% vs 4.3%, respectively, risk difference 8.09%; 95% confidence interval [CI]: 3.76-12.41; p=0.0002); the rates of BARC 3-5 type bleeding were relatively high but not statistically different compared with HBR- patients (7.7% vs 6.1%, risk difference 1.67%; 95% CI: -2.72 to 6.06; p=0.46). Subgroup analyses for bleeding events showed no significant interaction in terms of STS-PROM score, age, or medications.The ARC-HBR criteria failed to isolate a subgroup of patients at higher bleeding risk in TAVR patients from a randomised trial. These findings have potential implications, especially for the selection of post-TAVR antithrombotic regimens based on individual bleeding-risk profiles. Specific HBR criteria should be defined for TAVR patients." @default.
• W4225699651 created "2022-05-05" @default.
• W4225699651 creator A5003272933 @default.
• W4225699651 creator A5003293616 @default.
• W4225699651 creator A5004334730 @default.
• W4225699651 creator A5004549218 @default.
• W4225699651 creator A5013303634 @default.
• W4225699651 creator A5019849556 @default.
• W4225699651 creator A5019997756 @default.
• W4225699651 creator A5022182831 @default.
• W4225699651 creator A5023187022 @default.
• W4225699651 creator A5040164000 @default.
• W4225699651 creator A5042630628 @default.
• W4225699651 creator A5042959417 @default.
• W4225699651 creator A5043598690 @default.
• W4225699651 creator A5057508716 @default.
• W4225699651 creator A5058660900 @default.
• W4225699651 creator A5064993872 @default.
• W4225699651 creator A5068286741 @default.
• W4225699651 creator A5072422669 @default.
• W4225699651 creator A5077802539 @default.
• W4225699651 creator A5087348787 @default.
• W4225699651 creator A5087550320 @default.
• W4225699651 creator A5091301686 @default.
• W4225699651 date "2022-08-01" @default.
• W4225699651 modified "2023-10-17" @default.
• W4225699651 title "Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2" @default.
• W4225699651 cites W1982135373 @default.
• W4225699651 cites W1992447975 @default.
• W4225699651 cites W1992557526 @default.
• W4225699651 cites W2122779695 @default.
• W4225699651 cites W2324073140 @default.
• W4225699651 cites W2913812593 @default.
• W4225699651 cites W2921388585 @default.
• W4225699651 cites W2973068166 @default.
• W4225699651 cites W2974530312 @default.
• W4225699651 cites W2980421898 @default.
• W4225699651 cites W2983368451 @default.
• W4225699651 cites W2987620153 @default.
• W4225699651 cites W3021403654 @default.
• W4225699651 cites W3027509262 @default.
• W4225699651 cites W3092570019 @default.
• W4225699651 cites W3093249073 @default.
• W4225699651 cites W3110765623 @default.
• W4225699651 cites W3112785303 @default.
• W4225699651 cites W3114905100 @default.
• W4225699651 cites W3127113499 @default.
• W4225699651 cites W3156434758 @default.
• W4225699651 cites W3159562574 @default.
• W4225699651 cites W3165991162 @default.
• W4225699651 cites W3173051613 @default.
• W4225699651 cites W3174528920 @default.
• W4225699651 cites W4225697631 @default.
• W4225699651 cites W4226036551 @default.
• W4225699651 doi "https://doi.org/10.4244/eij-d-21-01048" @default.
• W4225699651 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35450838" @default.
• W4225699651 hasPublicationYear "2022" @default.
• W4225699651 type Work @default.
• W4225699651 citedByCount "5" @default.
• W4225699651 countsByYear W42256996512022 @default.
• W4225699651 countsByYear W42256996512023 @default.
• W4225699651 crossrefType "journal-article" @default.
• W4225699651 hasAuthorship W4225699651A5003272933 @default.
• W4225699651 hasAuthorship W4225699651A5003293616 @default.
• W4225699651 hasAuthorship W4225699651A5004334730 @default.
• W4225699651 hasAuthorship W4225699651A5004549218 @default.
• W4225699651 hasAuthorship W4225699651A5013303634 @default.
• W4225699651 hasAuthorship W4225699651A5019849556 @default.
• W4225699651 hasAuthorship W4225699651A5019997756 @default.
• W4225699651 hasAuthorship W4225699651A5022182831 @default.
• W4225699651 hasAuthorship W4225699651A5023187022 @default.
• W4225699651 hasAuthorship W4225699651A5040164000 @default.
• W4225699651 hasAuthorship W4225699651A5042630628 @default.
• W4225699651 hasAuthorship W4225699651A5042959417 @default.
• W4225699651 hasAuthorship W4225699651A5043598690 @default.
• W4225699651 hasAuthorship W4225699651A5057508716 @default.
• W4225699651 hasAuthorship W4225699651A5058660900 @default.
• W4225699651 hasAuthorship W4225699651A5064993872 @default.
• W4225699651 hasAuthorship W4225699651A5068286741 @default.
• W4225699651 hasAuthorship W4225699651A5072422669 @default.
• W4225699651 hasAuthorship W4225699651A5077802539 @default.
• W4225699651 hasAuthorship W4225699651A5087348787 @default.
• W4225699651 hasAuthorship W4225699651A5087550320 @default.
• W4225699651 hasAuthorship W4225699651A5091301686 @default.
• W4225699651 hasBestOaLocation W42256996512 @default.
• W4225699651 hasConcept C126322002 @default.
• W4225699651 hasConcept C131872663 @default.
• W4225699651 hasConcept C164705383 @default.
• W4225699651 hasConcept C2777364248 @default.
• W4225699651 hasConcept C2778213512 @default.
• W4225699651 hasConcept C2780400711 @default.
• W4225699651 hasConcept C44249647 @default.
• W4225699651 hasConcept C45393284 @default.
• W4225699651 hasConcept C500558357 @default.
• W4225699651 hasConcept C71924100 @default.
• W4225699651 hasConceptScore W4225699651C126322002 @default.
• W4225699651 hasConceptScore W4225699651C131872663 @default.
• W4225699651 hasConceptScore W4225699651C164705383 @default.

• next